Annual report pursuant to Section 13 and 15(d)

NOTE 7. REVERSE ACQUISITION (Tables)

v2.4.0.6
NOTE 7. REVERSE ACQUISITION (Tables)
12 Months Ended
Dec. 31, 2012
Note 7. Reverse Acquisition Tables  
Pro forma results

If TransBiotec - DE’s operating activity for the year ended December 31, 2011 is combined with TransBiotec - CA’s activity for the same period, the pro forma results are as follows:

 

    2011  
       
Pro forma revenue   $ -  
         
Pro forma net income (loss)   $ (1,130,068 )
         
Pro forma net income (loss) per share   $ (.10 )
         
Pro forma weighted average Common shares outstanding     11,344,444